Price T Rowe Associates Inc. MD Trims Stock Holdings in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)
Price T Rowe Associates Inc. MD lowered its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 13.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 26,546 shares of the company’s stock after selling 3,989 shares during the period. Price T Rowe Associates Inc. MD’s holdings in 4D Molecular Therapeutics […]
Price T Rowe Associates Inc. MD lowered its position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Free Report) by 13.1% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 26,546 shares of the company’s stock after selling 3,989 shares during the period. Price T Rowe Associates Inc. MD’s holdings in 4D Molecular Therapeutics […]
